These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17488663)

  • 41. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
    Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
    Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions.
    Falini B
    Am J Hematol; 2023 Sep; 98(9):1452-1464. PubMed ID: 37317978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
    Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
    Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of anaplastic lymphoma kinase variant translocations using 5'RACE.
    Hernández L; Campo E
    Methods Mol Med; 2005; 115():295-314. PubMed ID: 15998975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
    Ahmad F; Mandava S; Das BR
    Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
    Ladanyi M
    Cancer Surv; 1997; 30():59-75. PubMed ID: 9547986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of normal and chimeric nucleophosmin in human cells.
    Cordell JL; Pulford KA; Bigerna B; Roncador G; Banham A; Colombo E; Pelicci PG; Mason DY; Falini B
    Blood; 1999 Jan; 93(2):632-42. PubMed ID: 9885226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
    Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.
    Chou WC; Tang JL; Lin LI; Yao M; Tsay W; Chen CY; Wu SJ; Huang CF; Chiou RJ; Tseng MH; Lin DT; Lin KH; Chen YC; Tien HF
    Cancer Res; 2006 Mar; 66(6):3310-6. PubMed ID: 16540685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
    Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
    Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
    Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
    Pasqualucci L; Liso A; Martelli MP; Bolli N; Pacini R; Tabarrini A; Carini M; Bigerna B; Pucciarini A; Mannucci R; Nicoletti I; Tiacci E; Meloni G; Specchia G; Cantore N; Di Raimondo F; Pileri S; Mecucci C; Mandelli F; Martelli MF; Falini B
    Blood; 2006 Dec; 108(13):4146-55. PubMed ID: 16926285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
    Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
    ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis.
    Mduff FK; Hook CE; Tooze RM; Huntly BJ; Pandolfi PP; Turner SD
    Lab Invest; 2011 Sep; 91(9):1298-303. PubMed ID: 21709672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements.
    Berger R; Busson M; Baranger L; Hélias C; Lessard M; Dastugue N; Speleman F
    Leukemia; 2006 Feb; 20(2):319-21. PubMed ID: 16341035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
    Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
    Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
    van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
    Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
    Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
    Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.
    Slupianek A; Nieborowska-Skorska M; Hoser G; Morrione A; Majewski M; Xue L; Morris SW; Wasik MA; Skorski T
    Cancer Res; 2001 Mar; 61(5):2194-9. PubMed ID: 11280786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.